Navigation Links
Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance Initiative
Date:9/1/2010

NASHVILLE, Tenn., Sept. 1 /PRNewswire/ -- Radiation Oncology Services of America, Inc. (ROSA), a subsidiary of Ambulatory Services of America, Inc. (ASA), announced today that it has entered into an agreement with the Department of Radiation Oncology at the Washington University in St. Louis School of Medicine to embark on a Cooperative Quality Assurance Project.  In this project, the Washington University Department of Radiation Oncology will review quality assurance activities in a number of ROSA's facilities and will work with ROSA to identify and build upon best clinical practices.

Greg Merrill, President and Chief Operating Officer of ROSA, said, "I am confident that all ROSA employees keep patient safety at the forefront of everything they do in our centers.  But we must also continually challenge ourselves to ensure that we are providing the best and safest patient care.  We welcome the chance to learn about ways to improve the quality of care in our delivery of radiation therapy for our patients."

As a nationally and internationally recognized expert in numerous radiation therapy procedures and practices, the Department of Radiation Oncology of Washington University in St. Louis operates an outreach program, known as Radiation Oncology Consulting Services (ROCS), which gathers knowledge from radiation oncology entities in academic settings as well as hospital-based and freestanding cancer centers and then distributes that shared knowledge base widely within the radiation oncology industry.  To kick off the Cooperative Quality Assurance Project, the Washington University in St. Louis' physics team will visit several ROSA centers in the upcoming months and will engage the staff in discussions around imaging and treatment planning, technology utilization, quality assurance and patient safety issues.  

The Department of Radiation Oncology at the Washington University in St. Louis School of Medicine is dedicated to excellence in patient care, teaching and research.  The department is one of the largest in the United States and a national leader in developing the most recent radiation treatments for cancer patients.  The department is a component of Mallinckrodt Institute of Radiology (MIR), which provides a rich endowment and remarkable environment for research and technology development.  The department consists of four divisions that include biology, physics and clinical divisions, plus a newly created division in bioinformatics and outcomes research.  Washington University School of Medicine is ranked among the nation's top five medical schools.

Ambulatory Services of America, headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians.  ASA, through its primary subsidiaries, Radiation Oncology Services of America, Inc. and Renal Services of America, Inc., owns, operates and manages facilities providing radiation oncology services and dialysis services.  ASA owns interests in and operates more than 45 dialysis centers and 18 radiation oncology centers in 12 states and the territory of Guam.  ASA also manages three other dialysis centers.


'/>"/>
SOURCE Ambulatory Services of America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
2. Beaumont Patients 1st to get Next Generation of Radiation Treatment
3. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
4. Alfacells ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
5. CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation
6. Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkins Lymphoma
7. Patients Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation
8. Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology
9. CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System
10. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
11. Breast MRI Scan Could Determine Need for Radiation Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Research and Markets has announced the addition of the ... to their offering. ... The latest research Fibromyalgia Drugs Price Analysis and Strategies - ... market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Fibromyalgia ...
(Date:2/23/2017)... Regulus Therapeutics Inc . (Nasdaq: RGLS), ... innovative medicines targeting microRNAs, today announced it will release ... Thursday, March 2, 2017 after the market closes. ... on March 2, 2017 at 5:00 p.m. Eastern Time ... results and provide a general business update.  A live ...
(Date:2/23/2017)... 23, 2017 According to a ... (X-ray Imaging Digital, Analog), MRI (Closed, Open), Ultrasound, CT, ... Oncology), End User (Hospitals, Imaging Centers) - Global Forecast ... global market over the forecast period of 2016 to ... Billion by 2021, at a CAGR of 6.6% from ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) ... company later this year. Dyer started as the Chairman of the Management Committee ... establishment of the corporation including the recruitment of investor/owners and development of the business ...
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... announced an official 2017 partnership with The Jensie Gran Fondo of Marin. For ... and UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The American Cleft ... ACPA’s 74th Annual Meeting. KLS is a longtime supporter of the event. , ... exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, ... symposium on “Doping in Sport: How the Culture Might Change,” in ... LLP. The symposium will be held at Pepperdine University in Malibu, California. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Healthcare Research & Analytics® (HRA®) ... fight against cancer, has produced a seminal study that asked cancer survivors and ... findings in a webinar, Defining Compassionate Care Through the Voices of Patients and ...
Breaking Medicine News(10 mins):